Position in VOR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$44,222,568
-$52,202,596 QoQ
Shares Held
2,402,095
-55.6% QoQ
Ownership
4.06%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#8
of 101 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VOR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RA CAPITAL MANAGEMENT, L.P. holds $11,082,969,028 across 75 Biotechnology names. VOR ranks #40 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
10,281,496 | $2,742,280,613 | |
| 2 | PBLS |
Parabilis Medicines, Inc.
|
28,933,371 | $791,906,364 | |
| 3 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
6,666,837 | $740,218,912 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
11,474,599 | $667,018,439 | |
| 5 | SION |
Sionna Therapeutics, Inc.
|
9,905,045 | $435,722,929 | |
| 6 | TYRA |
Tyra Biosciences, Inc.
|
12,198,625 | $389,624,082 | |
| 7 | EWTX |
Edgewise Therapeutics, Inc.
|
8,392,730 | $340,996,619 | |
| 8 | NAMS |
NewAmsterdam Pharma Co N.V.
|
9,883,524 | $330,779,298 |
All Filings in VOR
Export CSV
35 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-07-16 | $224,342,405 | 12,937,855 | Shares | Sole | 2026-07-21 | |
| 2026-06-30 | $44,222,568 | 2,402,095 | Shares | Sole | 2026-08-14 | |
| 2026-04-20 | $201,959,487 | 12,896,519 | Shares | Sole | 2026-04-21 | |
| 2026-04-14 | $203,824,384 | 12,739,024 | Shares | Sole | 2026-04-15 | |
| 2026-04-09 | $195,852,415 | 12,554,642 | Shares | Sole | 2026-04-10 | |
| 2026-04-06 | $201,743,216 | 12,399,706 | Shares | Sole | 2026-04-08 | |
| 2026-03-31 | $96,425,164 | 5,404,998 | Shares | Sole | 2026-05-15 | |
| 2026-03-30 | $179,156,602 | 12,187,524 | Shares | Sole | 2026-04-01 | |
| 2026-03-12 | $126,774,105 | 9,023,068 | Shares | Sole | 2026-03-16 | |
| 2025-12-31 | $70,697,373 | 5,404,998 | Shares | Sole | 2026-02-17 | |
| 2025-12-18 | $69,267,468 | 5,411,521 | Shares | Sole | 2025-12-18 | |
| 2025-11-12 | $23,593,486 | 2,345,277 | Shares | Sole | 2025-11-14 | |
| 2025-10-28 | $21,165,527 | 786,092 | Shares | Sole | 2025-10-30 | |
| 2025-10-23 | $32,937,240 | 1,186,500 | Shares | Sole | 2025-10-27 | |
| 2025-10-16 | $41,634,058 | 1,432,693 | Shares | Sole | 2025-10-20 | |
| 2025-09-30 | $96,577,704 | 1,982,301 | Shares | Sole | 2025-11-14 | |
| 2025-09-17 | $60,455,172 | 1,988,657 | Shares | Sole | 2025-09-19 | |
| 2025-06-30 | $64,226,583 | 39,646,039 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $28,465,856 | 39,646,039 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $44,007,103 | 39,646,039 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $15,924,216 | 22,748,880 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $22,748,880 | 22,748,880 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $53,914,845 | 22,748,880 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $51,184,980 | 22,748,880 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $48,227,625 | 22,748,880 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $70,294,039 | 22,748,880 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $122,388,974 | 22,748,880 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $151,280,052 | 22,748,880 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $44,261,472 | 11,120,973 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $55,271,235 | 11,120,973 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $67,170,676 | 11,120,973 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $129,225,706 | 11,120,973 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $174,376,856 | 11,120,973 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $207,406,146 | 11,120,973 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $479,313,936 | 11,120,973 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||